|Articles|February 1, 2010

Applied Clinical Trials

  • Applied Clinical Trials-02-01-2010
  • Volume 0
  • Issue 0

Applied Clinical Trials Digital Edition - February 2010

REGULATORY : Avoiding Adverse Event Setbacks in Early Studies TRIAL DESIGN : Proposed Payment Models For the Phase I Volunteer European Pediatric Survey Unveils Research Challenges Also in this issue : FDA Commissioner Wraps Up Her First Year, EU Focuses on Inclusion of Elderly in Trials, Clinical Data Warehouses Stall in Real World, How Pediatric Networks Benefit Children

Articles in this issue

almost 17 years ago

Prepare Early for Adverse Events

almost 17 years ago

Paying the Phase I Volunteer

almost 17 years ago

When Great Ideas Meet the Real World

almost 17 years ago

Science and Research Top FDA Priorities

almost 17 years ago

EMEA Sees Benefits for Children

almost 17 years ago

Aging Under the Microscope in Europe

almost 17 years ago

How to Improve Children's Research

almost 17 years ago

Cardiovascular Drug Activity

Related to this article

The Next Evolution of Patient-Centered Trials Starts with Design
Decentralized trial success depends less on how far activities move away from sites than on matching each activity’s delivery model to participant burden, site readiness, and data integrity, using patient intelligence to decide where flexibility helps and where site-based care remains essential.
© putilov_denis - © putilov_denis - stock.adobe.com
Sponsors rigorously vet CROs for oncology expertise but rarely apply the same scrutiny to the IRB reviewing their trials, even though increasingly complex protocols require reviewers with substantive therapeutic knowledge, not just a rostered oncologist.